ADHD, substance use disorders and stimulant treatment: understanding the relationships.
作者信息
Newcorn Jeffrey H
机构信息
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
出版信息
World Psychiatry. 2025 Oct;24(3):377-378. doi: 10.1002/wps.21348.
Abstract
摘要
相似文献
1
ADHD, substance use disorders and stimulant treatment: understanding the relationships.注意力缺陷多动障碍、物质使用障碍与兴奋剂治疗：理解它们之间的关系。
World Psychiatry. 2025 Oct;24(3):377-378. doi: 10.1002/wps.21348.
2
Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood.兴奋剂治疗与物质使用的关联：从青少年到成年早期。
JAMA Psychiatry. 2023 Sep 1;80(9):933-941. doi: 10.1001/jamapsychiatry.2023.2157.
3
Telehealth Prescribing of Stimulants for ADHD and Associated Risk for Later Stimulant and Substance Use Disorders.用于治疗注意力缺陷多动障碍（ADHD）的兴奋剂的远程医疗处方及后续使用兴奋剂和物质使用障碍的相关风险。
Am J Psychiatry. 2025 Aug 1;182(8):779-788. doi: 10.1176/appi.ajp.20240346. Epub 2025 Jun 11.
4
ADHD, stimulant medication use, and the risk of fracture: a systematic review and meta-analysis.注意缺陷多动障碍（ADHD）、兴奋剂药物使用与骨折风险：系统评价和荟萃分析。
Arch Osteoporos. 2021 Jun 2;16(1):81. doi: 10.1007/s11657-021-00960-3.
5
Cannabis Use in a Community-Based Sample of Adults Diagnosed With ADHD: Prevalence, Impact on Symptoms, and Stimulant Side Effects.在一个基于社区的成人多动症样本中使用大麻：患病率、对症状的影响及兴奋剂副作用
J Atten Disord. 2025 Aug 28:10870547251364575. doi: 10.1177/10870547251364575.
6
Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.用于治疗注意力缺陷多动障碍的兴奋剂的滥用与转移：文献系统综述
J Am Acad Child Adolesc Psychiatry. 2008 Jan;47(1):21-31. doi: 10.1097/chi.0b013e31815a56f1.
7
Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020.接受物质使用治疗的阿片类物质使用障碍患者中兴奋剂使用的趋势：一项2013年至2020年前瞻性队列研究的结果
Drug Alcohol Depend. 2025 Aug 1;273:112703. doi: 10.1016/j.drugalcdep.2025.112703. Epub 2025 May 16.
8
Examining daily stimulant medication use and sleep in adolescents with ADHD.研究多动症青少年每日使用兴奋剂药物与睡眠的情况。
Eur Child Adolesc Psychiatry. 2024 Mar;33(3):821-832. doi: 10.1007/s00787-023-02204-w. Epub 2023 Apr 12.
9
Adolescents' Use of Medications for Attention-Deficit/Hyperactivity Disorder and Subsequent Risk of Nonmedical Stimulant Use.青少年使用治疗注意力缺陷多动障碍的药物与随后非医疗性使用兴奋剂的风险。
J Adolesc Health. 2024 Jul;75(1):188-191. doi: 10.1016/j.jadohealth.2024.01.024. Epub 2024 Mar 13.
10
Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.兴奋剂和非兴奋剂药物治疗注意缺陷多动障碍和癫痫患者。
Cochrane Database Syst Rev. 2022 Jul 13;7(7):CD013136. doi: 10.1002/14651858.CD013136.pub2.
本文引用的文献
1
Attention-Deficit Hyperactivity Disorder Stimulant Therapy and Prescription Drug Misuse During Transition to Young Adulthood.注意缺陷多动障碍兴奋剂治疗与向成年早期过渡期间的处方药物滥用。
Psychiatr Serv. 2024 Jul 1;75(7):622-629. doi: 10.1176/appi.ps.20230418. Epub 2024 Feb 7.
2
Association Between Stimulant Treatment and Substance Use Through Adolescence Into Early Adulthood.兴奋剂治疗与物质使用的关联：从青少年到成年早期。
JAMA Psychiatry. 2023 Sep 1;80(9):933-941. doi: 10.1001/jamapsychiatry.2023.2157.
3
Sensitization-based risk for substance abuse in vulnerable individuals with ADHD: Review and re-examination of evidence.注意力缺陷多动障碍（ADHD）易感个体中基于致敏作用的物质滥用风险：证据综述与重新审视
Neurosci Biobehav Rev. 2022 Apr;135:104575. doi: 10.1016/j.neubiorev.2022.104575. Epub 2022 Feb 10.
4
Systematic Review: Nonmedical Use of Prescription Stimulants: Risk Factors, Outcomes, and Risk Reduction Strategies.系统评价：处方兴奋剂的非医疗使用：风险因素、后果和风险降低策略。
J Am Acad Child Adolesc Psychiatry. 2020 Jan;59(1):100-112. doi: 10.1016/j.jaac.2019.06.012. Epub 2019 Jul 19.
5
International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.国际物质使用障碍共病注意缺陷/多动障碍患者筛查、诊断和治疗共识声明。
Eur Addict Res. 2018;24(1):43-51. doi: 10.1159/000487767. Epub 2018 Mar 6.
6
Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.延释混合安非他命盐类与安慰剂治疗共病成人注意缺陷/多动障碍和可卡因使用障碍：一项随机临床试验。
JAMA Psychiatry. 2015 Jun;72(6):593-602. doi: 10.1001/jamapsychiatry.2015.41.
7
Stimulant ADHD medication and risk for substance abuse.刺激性多动症药物与药物滥用风险。
J Child Psychol Psychiatry. 2014 Aug;55(8):878-85. doi: 10.1111/jcpp.12164. Epub 2013 Oct 25.
8
Stimulant medication and substance use outcomes: a meta-analysis.兴奋剂药物和物质使用结果的荟萃分析。
JAMA Psychiatry. 2013 Jul;70(7):740-9. doi: 10.1001/jamapsychiatry.2013.1273.
Zotero 插件